Comparison of VA (Venetoclax, Azacitidine), VACl (VA, Cladribine), VACh (VA, Chidamide), and Alternating VACl/VACh in Newly Diagnosed Acute Myeloid Leukemia
Clinical trial NCT06532552 · RECRUITING
Trial details
- NCT number
- NCT06532552
- Sponsor
- The First Affiliated Hospital of Soochow University
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-29
- Primary completion
- 2027-08-01
- Enrollment
- 172
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.